#header #header-bottom .menu-wrapper{display: block!important;}

Attention javascript est désactivé sur votre poste.
Ce site nécessite l'activation de javascript pour fonctionner correctement.

Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease

Home . Resources . Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Receive our general news!